Chapter 56 Breast Cancer : Early Stage Flashcards
Boundary of Breast
Superficial to Pectoralis major Midline to mid axillary line Cranially 2nd anterior rib Caudally 6th anterior rib Upper outer quadrant may extend to axillary tail of Spence
Contents of chest wall
Ribs
Intercostal muscles
Serratus anterior muscle(not pectoral muscle)
Where does most breast cancer develop anatomically?
Interface between ductal system and lobules, region called terminal ductal lobular unit
Lymphatic drainage of breast
Predominant axillary lymph nodes
Supraclavicular lymph nodes
Internal mammary lymph nodes
Describe division of axillary nodes
In relation to pectoral minor muscle
Level 1 caudal and lateral to muscle
Level 2 beneath the muscle
Level 3(Infraclavicular region) cranial and medial to muscle
Describe IMC lymph nodes
IMC lie along internal mammary vessels
3-4cm lateral to midline
First 3 intercostal space nodes are usually involved
Drainage of IMC lymph nodes
Medial, central and lower breast
Describe process of sentinel lymph node imaging
Use of lymphoscintigraphy by injecting technicium-99 radiocolloid into peritumoral region followed by scintillation scanning.
Causes of breast cancer
Older age (>50 years) Age of menarche(early) and menopause(late) Late age of first child birth, Nulliparity Family history Geographic and ethnic variability Life style(Obesity) Personal(dense breast) Radiation induced Hormonal therapy induced Dietary factors(alcohol)
What percentage of postmenopausal hormonal replacement therapy increased annual relative risk of developing breast cancer?
2.3%
Randomized trial of postmenopausal hormonal therapy from Women’s health initiative group E+P vs Placebo
What percentage had breast cancer
24% increase in breast cancer, coronary heart disease, stroke, pulmonary emboli
What percentage of women would have increased relative risk of breast cancer
Use of E+P vs non-user
8%
What percentage of women would have increased relative risk of breast cancer
Use of Estrogen only vs non-user
1%
Use of hormonal replacement therapy in women who have undergone hysterectomy
Estrogen only has minimal effect on breast cancer risk
Use of hormonal replacement therapy in women who have not undergone hysterectomy
Estrogen and Progesterone remains standard to avoid risk of endometrial cancer associated with unopposed estrogen replacement